Incidence of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialised countries: The EXPLORE study

Yamamoto-Furusho, JK; Al Harbi, O; Armuzzi, A; Chan, W; de Leon, EP; Qian, JM; Shapina, M; Toruner, M; Tu, CH; Ye, BD; Guennec, M; Sison, C; Demuth, D; Fadeeva, O; Khan, QMR

Yamamoto-Furusho, JK (corresponding author), Natl Inst Med Sci & Nutr, Dept Gastroenterol, Inflammatory Bowel Dis Clin, Vasco de Quiroga 15 Colonia Belisario Dominguez S, Mexico City 14080, DF, Mexico.

DIGESTIVE AND LIVER DISEASE, 2020; 52 (8): 869

Abstract

Background: Incidence of inflammatory bowel disease (IBD) is increasing in newly industrialised countries (NICs); however, data on suboptimal response......

Full Text Link